ZA200202655B - Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor. - Google Patents

Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.

Info

Publication number
ZA200202655B
ZA200202655B ZA200202655A ZA200202655A ZA200202655B ZA 200202655 B ZA200202655 B ZA 200202655B ZA 200202655 A ZA200202655 A ZA 200202655A ZA 200202655 A ZA200202655 A ZA 200202655A ZA 200202655 B ZA200202655 B ZA 200202655B
Authority
ZA
South Africa
Prior art keywords
hexahydrofuro
ylsulfonyl
benzodioxol
furan
carbamate
Prior art date
Application number
ZA200202655A
Other languages
English (en)
Inventor
Piet Tom Bert Paul Wigerinck
Guangyang Wang
Michael Eissenstat
John W Erickson
Original Assignee
Tibotec Pharm Ltd
Nat Inst Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd, Nat Inst Health filed Critical Tibotec Pharm Ltd
Publication of ZA200202655B publication Critical patent/ZA200202655B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA200202655A 1999-10-06 2002-04-04 Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor. ZA200202655B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15785099P 1999-10-06 1999-10-06

Publications (1)

Publication Number Publication Date
ZA200202655B true ZA200202655B (en) 2003-09-23

Family

ID=22565540

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200202655A ZA200202655B (en) 1999-10-06 2002-04-04 Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.

Country Status (26)

Country Link
US (2) US6649651B1 (zh)
EP (1) EP1222192B8 (zh)
JP (1) JP4951179B2 (zh)
KR (1) KR100792391B1 (zh)
CN (1) CN1191256C (zh)
AP (1) AP1459A (zh)
AT (1) ATE398623T1 (zh)
AU (1) AU781656B2 (zh)
BR (1) BR0014602A (zh)
CA (1) CA2386850C (zh)
CZ (1) CZ300031B6 (zh)
DE (1) DE60039244D1 (zh)
DK (1) DK1222192T3 (zh)
ES (1) ES2307533T3 (zh)
HK (1) HK1054746A1 (zh)
HU (1) HU228938B1 (zh)
IL (2) IL149005A0 (zh)
MX (1) MXPA02003607A (zh)
NO (1) NO327996B1 (zh)
NZ (1) NZ518580A (zh)
OA (1) OA12053A (zh)
PL (1) PL204924B1 (zh)
RU (1) RU2247123C2 (zh)
SK (1) SK287153B6 (zh)
WO (1) WO2001025240A1 (zh)
ZA (1) ZA200202655B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12053A (en) * 1999-10-06 2006-05-02 Tibotec Pharm Ltd HexahydrofuroÄ2,3-bÜfuran-3-yl-N-ä3-Ä(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)aminoÜ-1-benzyl-2-hydroxypropylücarbamate as retroviral protease inhibitor.
CZ303139B6 (cs) * 2001-04-09 2012-04-25 Tibotec Pharmaceuticals Ltd. 2-(substituovaný amino)-benzoxazolsulfonamidový derivát, farmaceutická kompozice s jeho obsahem a zpusob in vitro inhibice retrovirové replikace
DE60234952D1 (de) * 2001-09-10 2010-02-11 Tibotec Pharm Ltd VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
AU2003202914A1 (en) * 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
SI1517899T1 (sl) 2002-05-17 2008-02-29 Tibotec Pharm Ltd Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji
CN101445493A (zh) * 2002-08-02 2009-06-03 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
WO2004060895A1 (ja) 2002-12-27 2004-07-22 Sumitomo Chemical Company, Limited ヘキサヒドロフロフラノール誘導体の製造方法、その中間体及びその製造方法
WO2005087728A1 (en) 2004-03-11 2005-09-22 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
TWI383975B (zh) 2004-03-31 2013-02-01 Tibotec Pharm Ltd 製備（３Ｒ，３ａＳ，６ａＲ）六氫-呋喃并〔２，３-ｂ〕呋喃-３-醇之方法
KR100698291B1 (ko) * 2004-12-29 2007-03-22 엘지전자 주식회사 조명계
AU2006217922B2 (en) 2005-02-25 2012-04-05 Janssen Sciences Ireland Uc Protease inhibitor precursor synthesis
EP2049506B2 (en) 2006-07-07 2024-05-08 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
CA2658545A1 (en) * 2006-07-24 2008-01-31 Gilead Sciences, Inc. Bisfuranyl protease inhibitors
SI2089371T1 (sl) 2006-11-09 2011-05-31 Tibotec Pharm Ltd Postopki za pripravo heksahidrofuro(2,3-b)furan-3-ola
EP2491785A1 (en) * 2006-11-21 2012-08-29 Purdue Research Foundation Method and compositions for treating HIV infections
LT2487166T (lt) 2007-02-23 2016-11-10 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
US7981929B2 (en) * 2007-03-16 2011-07-19 Sequoia Pharmaceuticals, Inc. Benzofuran derived HIV protease inhibitors
CA2692331A1 (en) 2007-07-06 2009-01-15 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
CA2710679A1 (en) 2008-01-04 2009-07-16 Gilead Sciences, Inc. Inhibitors of cytochrome p450
WO2009091941A1 (en) * 2008-01-17 2009-07-23 Purdue Research Foundation Small molecule inhibitors of hiv proteases
US8791135B2 (en) 2008-07-01 2014-07-29 Purdue Research Foundation Nonpeptide HIV-1 protease inhibitors
WO2010006050A1 (en) * 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
CA2784530C (en) 2009-12-21 2018-05-22 Janssen R&D Ireland Degradable removable implant for the sustained release of an active compound
DK2643326T3 (en) 2010-11-23 2017-01-09 Mylan Laboratories Ltd A process for the preparation of (3R, 3aS, 6aR) -hexahydrofuro [2,3-b] furan-3-ol
JPWO2014024898A1 (ja) 2012-08-09 2016-07-25 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123065T3 (es) * 1992-08-25 1999-01-01 Searle & Co Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
DE69415326T2 (de) * 1993-08-24 1999-06-02 G.D. Searle & Co., Chicago, Ill. Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
WO1999067417A2 (en) 1998-06-23 1999-12-29 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Fitness assay and associated methods
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
OA12053A (en) * 1999-10-06 2006-05-02 Tibotec Pharm Ltd HexahydrofuroÄ2,3-bÜfuran-3-yl-N-ä3-Ä(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)aminoÜ-1-benzyl-2-hydroxypropylücarbamate as retroviral protease inhibitor.

Also Published As

Publication number Publication date
AU781656B2 (en) 2005-06-02
HUP0203130A2 (hu) 2003-01-28
HUP0203130A3 (en) 2005-01-28
JP2003511383A (ja) 2003-03-25
DK1222192T3 (da) 2008-10-20
PL204924B1 (pl) 2010-02-26
US6649651B1 (en) 2003-11-18
CZ20021419A3 (cs) 2002-10-16
IL149005A0 (en) 2002-11-10
ES2307533T3 (es) 2008-12-01
KR100792391B1 (ko) 2008-01-08
NO20021598D0 (no) 2002-04-04
CZ300031B6 (cs) 2009-01-14
NO20021598L (no) 2002-05-29
HK1054746A1 (en) 2003-12-12
SK5702002A3 (en) 2003-01-09
MXPA02003607A (es) 2003-07-28
WO2001025240A1 (en) 2001-04-12
SK287153B6 (sk) 2010-01-07
EP1222192B8 (en) 2008-10-01
DE60039244D1 (de) 2008-07-31
RU2247123C2 (ru) 2005-02-27
US7157495B2 (en) 2007-01-02
CA2386850C (en) 2010-03-30
CN1191256C (zh) 2005-03-02
NO327996B1 (no) 2009-11-02
PL354351A1 (en) 2004-01-12
OA12053A (en) 2006-05-02
HU228938B1 (hu) 2013-06-28
KR20020067503A (ko) 2002-08-22
EP1222192A1 (en) 2002-07-17
IL149005A (en) 2006-12-31
CN1407987A (zh) 2003-04-02
CA2386850A1 (en) 2001-04-12
ATE398623T1 (de) 2008-07-15
EP1222192B1 (en) 2008-06-18
JP4951179B2 (ja) 2012-06-13
NZ518580A (en) 2004-01-30
AP1459A (en) 2005-08-22
BR0014602A (pt) 2002-06-11
US20050261364A1 (en) 2005-11-24
AP2002002472A0 (en) 2002-06-30
AU7663800A (en) 2001-05-10

Similar Documents

Publication Publication Date Title
ZA200202655B (en) Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol -5-ylsulfonyl) (isobutyl) amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor.
WO1999064047A8 (en) Novel antiviral compounds
ZA200107496B (en) Amine derivatives as protease inhitors.
ZA992447B (en) Quinoxalinones as serine protease inhibitors.
ZA200204283B (en) Novel antidiabetic agents.
ZA992344B (en) Game machine.
ZA991551B (en) 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines.
ZA200004319B (en) Game machine.
ZA200407817B (en) 2-(2,6-Dichlorophenyl)-diarylimidazoles.
ZA992448B (en) Quinoxalinones as serine protease inhibitors.
MXPA02005792A (es) 1-(aminofenil)-2-pirrolidonas como inhibidores de la integrina.
ZA991548B (en) 6,9-Disubstituted 2-[trans-(4-Aminocyclohexyl) Amino] Purines.
ZA200107096B (en) Woodworking jig.
ZA992445B (en) Benzoxazinones/benzothiazinones as serine protease inhibitors.
HK1035922A1 (en) Tack for button.
ZA200004373B (en) Game machine.
ZA985885B (en) External abrasive machine.
ZA99873B (en) Novel dihydroxyhexanoic acid derivatives.
ZA200110021B (en) Substituted imidazothiazoles as antidepressant agents.
ZA978552B (en) Retroviral protease inhibiting compounds.
WO2001007408A3 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
ZA992214B (en) Oligomeric stabilizer mixture.
IL158033A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
ZA981168B (en) Compounds and processes for making herbicidal sulfonamides.
ZA200202765B (en) Grinding head.